Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
7.22M
-
Shares change
-
-386K
-
Total reported value, excl. options
-
$21.7M
-
Value change
-
-$1.34M
-
Number of buys
-
7
-
Number of sells
-
-3
-
Price
-
$3.02
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2015
14 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q2 2015.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.22M shares
of 131M outstanding shares and own 5.53% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (2.55M shares), GREAT POINT PARTNERS LLC (1.94M shares), RA CAPITAL MANAGEMENT, LLC (1.14M shares), BAKER BROS. ADVISORS LP (711K shares), Longwood Capital Partners LLC (525K shares), MILLENNIUM MANAGEMENT LLC (145K shares), Lombard Odier Asset Management (USA) Corp (104K shares), Cheyne Capital Management (UK) LLP (90K shares), ROYAL BANK OF CANADA (10.9K shares), and Tower Research Capital LLC (TRC) (3.7K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.